169 related articles for article (PubMed ID: 17980094)
21. Histopathology of endometrial hyperplasia and endometrial carcinoma. An update by Dr LC Horn et al in Annals of Diagnostic Pathology 2007;11:297-311.
Zheng W; Chambers SK
Ann Diagn Pathol; 2008 Jun; 12(3):231-2; author reply 232-3. PubMed ID: 18486902
[No Abstract] [Full Text] [Related]
22. Stage II uterine papillary serous carcinoma: Carboplatin/paclitaxel chemotherapy improves recurrence and survival outcomes.
Fader AN; Nagel C; Axtell AE; Zanotti KM; Kelley JL; Moore KN; Secord AA; Walsh CS; Huh WK; Gehrig PA; Gibbons H; Rose PG; Havrilesky LJ; Tuller E; Drake RD; Bottsford-Miller J; O'Malley DM;
Gynecol Oncol; 2009 Mar; 112(3):558-62. PubMed ID: 19118888
[TBL] [Abstract][Full Text] [Related]
23. [Preinvasive lesions in gynaecology - endometrium].
Feranec R; Mouková L; Chovanec J
Klin Onkol; 2013; 26 Suppl():S52-3. PubMed ID: 24325166
[TBL] [Abstract][Full Text] [Related]
24. Uterine papillary serous carcinoma: epidemiology, pathogenesis and management.
Fader AN; Boruta D; Olawaiye AB; Gehrig PA
Curr Opin Obstet Gynecol; 2010 Feb; 22(1):21-9. PubMed ID: 19952744
[TBL] [Abstract][Full Text] [Related]
25. Pilot phase II trial of radiation "sandwiched" between combination paclitaxel/platinum chemotherapy in patients with uterine papillary serous carcinoma (UPSC).
Fields AL; Einstein MH; Novetsky AP; Gebb J; Goldberg GL
Gynecol Oncol; 2008 Jan; 108(1):201-6. PubMed ID: 17997145
[TBL] [Abstract][Full Text] [Related]
26. Uterine serous carcinoma and endometrial intraepithelial carcinoma arising in endometrial polyps: report of 5 cases, including 2 associated with tamoxifen therapy.
McCluggage WG; Sumathi VP; McManus DT
Hum Pathol; 2003 Sep; 34(9):939-43. PubMed ID: 14562291
[TBL] [Abstract][Full Text] [Related]
27. The efficacy of adjuvant platinum-based chemotherapy in Stage I uterine papillary serous carcinoma (UPSC).
Dietrich CS; Modesitt SC; DePriest PD; Ueland FR; Wilder J; Reedy MB; Pavlik EJ; Kryscio R; Cibull M; Giesler J; Manahan K; Huh W; Cohn D; Powell M; Slomovitz B; Higgins RV; Merritt W; Hunter J; Puls L; Gehrig P; van Nagell JR
Gynecol Oncol; 2005 Dec; 99(3):557-63. PubMed ID: 16154185
[TBL] [Abstract][Full Text] [Related]
28. Precursors of endometrial cancer.
Sherman AI
Isr J Med Sci; 1978 Mar; 14(3):370-8. PubMed ID: 640822
[No Abstract] [Full Text] [Related]
29. [Activity of paclitaxel, epirubicin and carboplatin in patients with advanced or recurrent endometrial cancer].
Nakashima R; Enomoto T; Murata Y; Fujita M
Nihon Rinsho; 2004 Oct; 62 Suppl 10():360-4. PubMed ID: 15535268
[No Abstract] [Full Text] [Related]
30. Optimal surgical debulking in uterine papillary serous carcinoma affects survival.
Patsavas K; Woessner J; Gielda B; Rotmensch J; Yordan E; Bitterman P; Guirguis A
Gynecol Oncol; 2011 Jun; 121(3):581-5. PubMed ID: 21440290
[TBL] [Abstract][Full Text] [Related]
31. Adjuvant therapy for patients with stage I papillary serous endometrial cancer.
Alobaid A; Bruchim I; Verkooijen H; Gauthier P; Petignat P
Eur J Surg Oncol; 2006 Apr; 32(3):358-62. PubMed ID: 16414233
[TBL] [Abstract][Full Text] [Related]
32. The use of paclitaxel and platinum-based chemotherapy in uterine papillary serous carcinoma.
Zanotti KM; Belinson JL; Kennedy AW; Webster KD; Markman M
Gynecol Oncol; 1999 Aug; 74(2):272-7. PubMed ID: 10419744
[TBL] [Abstract][Full Text] [Related]
33. [Morphogenesis of cancer of the corpus uteri].
Cherkasskiĭ LA; Dlesovskikh LD
Vopr Onkol; 1973; 19(1):52-8. PubMed ID: 4701925
[No Abstract] [Full Text] [Related]
34. Neoadjuvant chemotherapy in uterine papillary serous carcinoma.
Resnik E; Taxy JB
Gynecol Oncol; 1996 Jul; 62(1):123-7. PubMed ID: 8690284
[TBL] [Abstract][Full Text] [Related]
35. The combination paclitaxel, carboplatin and megestrol acetate is effective in women with recurrent uterine papillary serous adenocarcinoma.
Eltabbakh GH; Moody J; Garafano LL; Hammond JM
Eur J Gynaecol Oncol; 1999; 20(1):18-9. PubMed ID: 10422674
[TBL] [Abstract][Full Text] [Related]
36. Human kallikrein 6: a new potential serum biomarker for uterine serous papillary cancer.
Santin AD; Diamandis EP; Bellone S; Soosaipillai A; Cane S; Palmieri M; Burnett A; Roman JJ; Pecorelli S
Clin Cancer Res; 2005 May; 11(9):3320-5. PubMed ID: 15867230
[TBL] [Abstract][Full Text] [Related]
37. Role of systematic lymphadenectomy and adjuvant therapy in stage I uterine papillary serous carcinoma.
Thomas MB; Mariani A; Cliby WA; Keeney GA; Podratz KC; Dowdy SC
Gynecol Oncol; 2007 Nov; 107(2):186-9. PubMed ID: 17688926
[TBL] [Abstract][Full Text] [Related]
38. Cystic neoplasms of the exocrine pancreas.
Campbell F; Azadeh B
Histopathology; 2008 Apr; 52(5):539-51. PubMed ID: 17903202
[TBL] [Abstract][Full Text] [Related]
39. STAT1 drives tumor progression in serous papillary endometrial cancer.
Kharma B; Baba T; Matsumura N; Kang HS; Hamanishi J; Murakami R; McConechy MM; Leung S; Yamaguchi K; Hosoe Y; Yoshioka Y; Murphy SK; Mandai M; Hunstman DG; Konishi I
Cancer Res; 2014 Nov; 74(22):6519-30. PubMed ID: 25267067
[TBL] [Abstract][Full Text] [Related]
40. Current treatment options for endometrial cancer.
Santin AD; Bellone S; O'Brien TJ; Pecorelli S; Cannon MJ; Roman JJ
Expert Rev Anticancer Ther; 2004 Aug; 4(4):679-89. PubMed ID: 15270671
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]